دورية أكاديمية
Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer
| العنوان: | Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer |
|---|---|
| المؤلفون: | Moore, Kathleen N., O'Malley, David M., Vergote, Ignace, Martin, Lainie P., Gonzalez-Martin, Antonio, Malek, Karim, Birrer, Michael J. |
| المصدر: | Gynecologic Oncology ; volume 151, issue 1, page 46-52 ; ISSN 0090-8258 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2018 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Obstetrics and Gynecology, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.ygyno.2018.07.017 |
| الإتاحة: | https://doi.org/10.1016/j.ygyno.2018.07.017Test https://api.elsevier.com/content/article/PII:S0090825818310813?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0090825818310813?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/ |
| رقم الانضمام: | edsbas.A74F8585 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ygyno.2018.07.017 |
|---|